![Cécile Chartier](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Cécile Chartier
Director/Board Member at
CELLECTIS S.A.
Profile
Cécile Chartier currently works at Cellectis SA, as Director from 2023 and NextVivo, Inc., as Chief Scientific Officer.
Dr. Chartier also formerly worked at Mereo BioPharma 5, Inc., as Senior Director-Target Validation and Iovance Biotherapeutics, Inc., as Vice President-Research from 2017 to 2021.
Dr. Chartier received her doctorate degree from Universite Louis Pasteur Strasbourg I.
Cécile Chartier active positions
| Companies | Position | Start |
|---|---|---|
| CELLECTIS S.A. | Director/Board Member | 27/06/2023 |
NextVivo, Inc.
 NextVivo, Inc. Packaged SoftwareTechnology Services Develops organoid technology platform for drug development services | Chief Tech/Sci/R&D Officer | - |
Former positions of Cécile Chartier
| Companies | Position | End |
|---|---|---|
| IOVANCE BIOTHERAPEUTICS, INC. | Chief Tech/Sci/R&D Officer | 01/01/2021 |
| ONCOMED PHARMACEUTICALS INC | Corporate Officer/Principal | - |
Training of Cécile Chartier
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
17
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Mereo BioPharma 5, Inc.
 Mereo BioPharma 5, Inc. Pharmaceuticals: MajorHealth Technology Develops anti-cancer stem cell therapeutics | Health Technology |
Cellectis SA
 Cellectis SA Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage biopharmaceutical company that develops immunotherapies | Health Technology |
Iovance Biotherapeutics, Inc.
 Iovance Biotherapeutics, Inc. BiotechnologyHealth Technology Develops biotechnological products for the treatment of cancer | Health Technology |
NextVivo, Inc.
NextVivo, Inc. Packaged SoftwareTechnology Services Develops organoid technology platform for drug development services | Technology Services |
Universite Louis Pasteur Strasbourg I
 Universite Louis Pasteur Strasbourg I Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Stock Market
- Insiders
- Cécile Chartier
